EditorialThe Pediatric Inflammatory Crohn’s Magnetic Resonance Enterography Index: A Step Forward for Transmural Pediatric Crohn’s Disease Monitoring and Healing
References (10)
- et al.
Crohn’s disease
Lancet
(2017) - et al.
STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD
Gastroenterology
(2021) - et al.
Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review
Lancet Gastroenterol Hepatol
(2021) - et al.
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease
Gut
(2009) - et al.
Development and validation of a simplified magnetic resonance index of activity for Crohn’s disease
Gastroenterology
(2019)
There are more references available in the full text version of this article.
Cited by (2)
The Role of Noninvasive Surrogates of Inflammation in Monitoring Pediatric Inflammatory Bowel Diseases: The Old and the New
2023, Gastroenterology Clinics of North America
Conflicts of interest Michael Todd Dolinger discloses consulting fees from Neurologica Corp, a subsidiary of Samsung Electronics Co, Ltd. Marla C. Dubinsky discloses consulting fees from AbbVie, Allergan, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Celgene, Ferring, Genentech, Gilead, Hoffmann-La Roche, Janssen, Pfizer, Prometheus Biosciences, Takeda, and Target PharmaSolutions, and research funding from AbbVie, Janssen, Pfizer, Prometheus Biosciences, and Takeda.
© 2022 by the AGA Institute.